CYP 0.00% 25.0¢ cynata therapeutics limited

Commercial Entrepreneurial Validation, page-40

  1. 9,241 Posts.
    This is becoming death by a 1000 cuts.

    We are all clearly supports of this company and its story however, we are also few and far between, when considering on market buyers.

    Question I am now asking myself is about management and 'if' they are correctly selling the story to the right target market.

    Let's face it, there are numerous company's with a great story that go nowhere.

    I do not likely saying this about a company that I have invested so much money in however, just like all of us, I don't have money to burn.

    Dyor!

    regards,
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.